Profile data is unavailable for this security.
About the company
Innovita Biological Technology Co Ltd is a China-based company mainly engaged in the research, development, production and sales of point-of-care testing (POCT) rapid diagnostic products. The Company's main products include novel coronavirus (2019-nCoV) neutralizing antibody detection kits using colloidal gold, quantum dot fluorescence immunochromatography and chemiluminescence techniques, and respiratory pathogen detection products, such as whole blood respiratory quintuple detection card, influenza virus triple detection card, virus serum quintuple detection card, respiratory pathogen nine indirect immunofluorescence kit, and others.
- Revenue in CNY (TTM)625.12m
- Net income in CNY266.22m
- Incorporated2006
- Employees404.00
- LocationInnovita Biological Technology Co LtdBEIJING 100071ChinaCHN
- Phone+86 1 083682249
- Fax+86 1 083682966
- Websitehttps://www.innovita.com.cn
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shanghai Yizhong Pharmaceutical Co Ltd | 336.56m | 135.71m | 5.26bn | 43.00 | 38.74 | 3.51 | -- | 15.63 | 0.66 | 0.66 | 1.64 | 7.28 | 0.2219 | 0.9416 | 3.28 | 7,826,913.00 | 8.95 | -0.9181 | 9.39 | -0.9485 | 93.54 | 93.19 | 40.32 | -6.11 | 12.66 | -- | 0.0342 | -- | 52.68 | -- | 13.09 | -- | 20.44 | -- |
| Zhejiang Shouxiangu Pharmaceuticl Co Ltd | 799.09m | 269.00m | 5.30bn | 1.14k | 19.11 | 2.29 | -- | 6.63 | 1.37 | 1.37 | 4.08 | 11.49 | 0.2573 | 0.9016 | 6.83 | 699,118.90 | 8.66 | 10.04 | 10.48 | 11.63 | 81.31 | 83.66 | 33.66 | 28.29 | 3.33 | -- | 0.2547 | 47.86 | -5.39 | 8.93 | -8.39 | 18.78 | 12.23 | 17.13 |
| Jiangsu Aidea Pharmaceutical Co Ltd | 391.64m | -90.16m | 5.31bn | 476.00 | -- | 4.76 | -- | 13.55 | -0.2106 | -0.2106 | 0.9303 | 2.65 | 0.227 | 1.23 | 1.98 | 822,765.80 | -5.23 | -2.40 | -7.18 | -2.85 | 44.46 | 39.00 | -23.02 | -10.15 | 1.20 | -- | 0.2992 | -- | 68.44 | 8.24 | 38.75 | -- | -4.47 | -- |
| Innovita Biological Technology Co Ltd | 625.12m | 266.22m | 5.50bn | 404.00 | 20.67 | 2.77 | -- | 8.80 | 1.96 | 1.96 | 4.59 | 14.62 | 0.3093 | 1.67 | 6.23 | 1,547,324.00 | 13.17 | -- | 14.20 | -- | 80.99 | -- | 42.59 | -- | 10.66 | -- | 0.0015 | -- | 7.03 | -- | 15.44 | -- | -- | -- |
| Guizhou Sanli Pharmaceutical Co Ltd | 1.71bn | 293.82m | 5.62bn | 2.28k | 19.63 | 3.61 | -- | 3.29 | 0.6988 | 0.6988 | 4.11 | 3.80 | 0.7064 | 2.58 | 3.81 | 748,477.00 | 12.34 | 12.39 | 18.37 | 16.72 | 71.52 | 70.45 | 17.47 | 16.31 | 1.67 | -- | 0.2368 | 25.70 | 36.10 | 17.75 | 45.42 | 21.51 | 127.48 | -- |
| Zhejiang Orient Gene Biotech Co Ltd | 627.03m | -414.61m | 5.65bn | 2.23k | -- | 0.7672 | -- | 9.01 | -2.05 | -2.05 | 3.11 | 36.51 | 0.065 | 0.9281 | 2.10 | 281,055.40 | -4.58 | 29.62 | -5.53 | 38.29 | 43.94 | 59.69 | -70.46 | 35.82 | 4.27 | -- | 0.0767 | 19.24 | -90.65 | 23.46 | -119.23 | -- | 121.04 | -- |
| Beijing Sun-Novo Pharma Research Co Ltd | 951.95m | 209.57m | 5.65bn | 1.37k | 26.97 | 5.57 | -- | 5.94 | 1.87 | 1.87 | 8.50 | 9.06 | 0.5465 | 26.19 | 1.77 | 694,854.30 | 11.70 | 12.99 | 19.13 | 21.70 | 59.10 | 53.93 | 21.40 | 21.34 | 1.77 | 45.00 | 0.3721 | 10.74 | 37.76 | 47.22 | 18.08 | 54.90 | 34.77 | -- |
| Sichuan Huiyu Pharmaceutical Co Ltd | 931.96m | 147.83m | 5.71bn | 1.36k | 38.63 | 1.50 | -- | 6.13 | 0.349 | 0.349 | 2.20 | 9.01 | 0.2032 | 0.9121 | 14.88 | 683,254.60 | 3.18 | 10.41 | 3.82 | 12.76 | 84.46 | 89.89 | 15.65 | 21.42 | 2.92 | -- | 0.1299 | 20.54 | -37.92 | 76.37 | -43.86 | -- | 66.72 | -- |
Data as of Jun 14 2024. Currency figures normalised to Innovita Biological Technology Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
15.39%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| China Asset Management Co., Ltd.as of 31 Dec 2023 | 2.16m | 7.22% |
| Rongtong Fund Management Co., Ltd.as of 31 Dec 2023 | 604.14k | 2.02% |
| CCB Principal Asset Management Co., Ltd.as of 31 Dec 2023 | 359.33k | 1.20% |
| Great Wall Fund Management Co., Ltd.as of 31 Dec 2023 | 350.00k | 1.17% |
| Everbright PGIM Fund Management Co. Ltd.as of 31 Dec 2023 | 343.01k | 1.15% |
| Hui'an Fund Management Co. Ltd.as of 30 Jun 2023 | 236.00k | 0.79% |
| CITIC-Prudential Fund Management Co., Ltd.as of 31 Dec 2023 | 219.60k | 0.74% |
| Maxwealth Fund Management Co., Ltd.as of 31 Dec 2023 | 181.00k | 0.61% |
| Bosera Asset Management Co., Ltd.as of 31 Dec 2023 | 106.48k | 0.36% |
| China Merchants Fund Management Co., Ltd.as of 31 Dec 2023 | 42.68k | 0.14% |
More ▼
Data from 31 Dec 2023 - 13 Jun 2024Source: FactSet Research Systems Inc.
